Adeno-associated virus (AAV)-mediated otoferlin (OTOF) gene therapy has been identified as a potential treatment for the hereditary autosomal recessive deafness 9 (DFNB9), caused by the pathogenic mutations in the OTOF gene [72]. Here, OTOF is linked to autosomal recessive nonsyndromic hearing loss 9.